Home › Funds › Cormorant Asset Management, LP › FTH

Cormorant Asset Management, LP position in FTH

FAETH THERAPEUTICS INC

Cormorant Asset Management, LP reported holding 1,028,242 shares of FTH (FAETH THERAPEUTICS INC) in its Q3 2026 13F filing — a position valued at US$30.6M, representing 2.19% of its reported portfolio and ranking #15 among its reported holdings. Cormorant Asset Management, LP has disclosed FTH holdings in 3 of the last 3 reported quarters, going back to Q1 2026.

Latest position (Q3 2026)1.03M sh
Reported value held$30.58M
Portfolio Weight2.19%
First reportedQ1 2026
Last changeHold
Updated2026-11-17

Last updated: 2026-11-17 · Source: SEC EDGAR Form 13F-HR

How Cormorant Asset Management, LP's FTH position evolved

Cormorant Asset Management, LP first disclosed a stake in FTH in Q1 2026 at 306,222 shares (US$9.7M). The position peaked in Q3 2026 at 1,028,242 shares, worth US$30.6M. Across 3 filings, Cormorant Asset Management, LP increased the stake 1 time(s), trimmed it 0 time(s) and left it unchanged 1 time(s). The most recent filing (Q3 2026) shows 1,028,242 shares valued at US$30.6M. Notable position changes include a 236% increase in Q2 2026 (shares rose 19% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q1 2026 306.22K $9.65M New
Q2 2026 1.03M $7.66M Add
Q3 2026 1.03M $30.58M Hold

Dots on the line are colored by change type; missing quarters mean no position was reported.

About FTH and 13F data

FTH (FAETH THERAPEUTICS INC) is a company whose sector is not yet classified in our data. 78 other funds we track also report a position in FTH — the largest reported positions include MONTANOVA CAPITAL, LLC (US$68.7M), Avoro Capital Advisors LLC (US$41.9M), Trails Edge Capital Partners, LP (US$28.0M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding FTH

All FTH fund holders →

FAQ

How long has Cormorant Asset Management, LP held FTH?

Cormorant Asset Management, LP has disclosed FTH holdings in 3 of the last 3 reported quarters, going back to Q1 2026.

What is Cormorant Asset Management, LP's current position in FTH?

As of Q3 2026, Cormorant Asset Management, LP holds 1.03M shares of FTH (FAETH THERAPEUTICS INC), valued at $30.58M, representing 2.19% of its reported portfolio and ranking #15.

Has Cormorant Asset Management, LP been buying or selling FTH?

In the latest 13F filing (Q3 2026), Cormorant Asset Management, LP held unchanged its position in FTH. The position peaked in Q3 2026 at 1.03M shares.

Which other funds hold FTH?

Other major institutional holders of FTH include MONTANOVA CAPITAL, LLC, Avoro Capital Advisors LLC, Trails Edge Capital Partners, LP, among 78 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.